Enem Nostrum Remedies Profile
Key Indicators
- Authorised Capital ₹ 4.35 Cr
- Paid Up Capital ₹ 2.35 Cr
- Company Age 24 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 40.62 Cr
- Satisfied Charges ₹ 104.21 Cr
- Revenue Growth 2.28%
- Profit Growth -38.48%
- Ebitda 15.80%
- Net Worth 1.79%
- Total Assets 14.27%
About Enem Nostrum Remedies
Enem Nostrum Remedies Private Limited (ENRPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 01 January 2001 and has a history of 24 years and two months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.35 Cr and a paid-up capital of Rs 2.35 Cr.
The company currently has active open charges totaling ₹40.62 Cr. The company has closed loans amounting to ₹104.21 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shraddha Dhamankar, Nirmal Mulye, and Anilkumar Mulye serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24229MH2001PTC130260
- Company No.
130260
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jan 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
What products or services does Enem Nostrum Remedies Private Limited offer?
Enem Nostrum Remedies Private Limited offers a wide range of products and services, including Medical Consultants & Clinics, Medical Consultancy Services, Pharma & Bioanalytical Services, Pharmaceutical Services, Research and Development (R&D) Work, Product Development Research, Company Law & Labour Law Consultants, Statutory Compliance Services, Analyzers & Analytical Instruments, Chromatographic Analyzer.
Enem Nostrum Remedies Private Limited
Explore comprehensive data for Enem Nostrum Remedies Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Enem Nostrum Remedies?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirmal Mulye  | Director | 14-Aug-2001 | Current |
Shraddha Dhamankar  | Director | 01-Jan-2001 | Current |
| Anilkumar Mulye | Additional Director | 18-Sep-2024 | Current |
Financial Performance of Enem Nostrum Remedies.
Enem Nostrum Remedies Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.28% increase. The company also saw a substantial fall in profitability, with a 38.48% decrease in profit. The company's net worth moved up by a moderate rise of 1.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Enem Nostrum Remedies?
In 2023, Enem Nostrum Remedies had a promoter holding of 99.99%. The company had 6 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Thurs Organics Private LimitedShraddha Dhamankar is a mutual person
Nexgen Healthcare Private LimitedShraddha Dhamankar and Anilkumar Mulye are mutual person
- Nli Healthcare (India) Private Limited
Shraddha Dhamankar, Nirmal Mulye and 1 more are mutual person
Symmetrix Biotech Private LimitedShraddha Dhamankar and Nirmal Mulye are mutual person
- Nostrum Technologies Private Limited
Shraddha Dhamankar, Nirmal Mulye and 1 more are mutual person
- Vidit Pharma Sciences Private Limited
Shraddha Dhamankar is a mutual person
Charges (Loans)
Open Charges
₹40.62 Cr
Satisfied Charges
₹104.21 Cr
Charges Breakdown by Lending Institutions
- Bank Of India : 37.11 Cr
- Biotechnology Industry Research Assistance Council : 2.56 Cr
- Others : 0.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Dec 2022 | Bank Of India | ₹37.11 Cr | Open |
| 11 Mar 2022 | Others | ₹4.77 M | Open |
| 04 Mar 2022 | Others | ₹4.77 M | Open |
| 14 Feb 2014 | Biotechnology Industry Research Assistance Council | ₹2.56 Cr | Open |
| 16 Dec 2021 | Hdfc Bank Limited | ₹21.89 Cr | Satisfied |
How Many Employees Work at Enem Nostrum Remedies?
Enem Nostrum Remedies has a workforce of 143 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Enem Nostrum Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enem Nostrum Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Enem Nostrum Remedies
Recent activity within the organization
- Director Appointment
Anilkumar Shridhar Mulye was appointed as a Additional Director was appointed as a Additional Director on 18 Sep 2024 & has been associated with this company since 5 months 24 days .
- Annual General Meeting
Enem Nostrum Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Charges
A charge with Bank Of India of Rs. 37.11 Cr registered on 05 Dec 2022 with Charge ID 100666599 was modified on 11 Jul 2023.
- Balance Sheet
Enem Nostrum Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
- Charges
A charge registered on 16 Dec 2021 via Charge ID 100514737 with Hdfc Bank Limited was fully satisfied on 21 Dec 2022.
- Charges
A charge with Bank Of India amounted to Rs. 37.11 Cr with Charge ID 100666599 was registered on 05 Dec 2022.
Frequently asked questions
What is the Incorporation or founding date of Enem Nostrum Remedies Private Limited?
Enem Nostrum Remedies Private Limited was incorporated on 01 Jan 2001.
What is authorized share capital and paid-up capital of Enem Nostrum Remedies Private Limited?
The authorized share capital of Enem Nostrum Remedies Private Limited is ₹ 4.35 Cr and paid-up capital is ₹ 2.35 Cr.
Who are the current board members & directors of Enem Nostrum Remedies Private Limited?
Currently 3 directors are associated with Enem Nostrum Remedies Private Limited.
- Shraddha Vinayak Dhamankar
- Nirmal Vasant Mulye
- Anilkumar Shridhar Mulye
What is the registered address of Enem Nostrum Remedies Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Enem Nostrum Remedies Private Limited is 201-204 Gayatri Commercial Complex Behind Mittal Ind.Estate Kurla-Andheri Road Andheri (E), India, Mumbai, Maharashtra, 400059.
What is the corporate identification number (CIN) and company number of Enem Nostrum Remedies Private Limited?
The corporate identification number (CIN) of Enem Nostrum Remedies Private Limited is U24229MH2001PTC130260 and the company number is 130260 as per Ministry of Corporate Affairs (MCA).
What is the official website of Enem Nostrum Remedies Private Limited?
The Official website of Enem Nostrum Remedies Private Limited is https://www.enemnostrum.com
What has been the recent revenue trend for Enem Nostrum Remedies Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Enem Nostrum Remedies Private Limited has risen by 2.28%.
How many employees does Enem Nostrum Remedies Private Limited currently have?
As Per 2023 financial reports, 143 employees are currently employed by Enem Nostrum Remedies Private Limited.
What change has been observed in the net worth of Enem Nostrum Remedies Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Enem Nostrum Remedies Private Limited has experienced an upsurge of 1.79%.
What are the total open charges for Enem Nostrum Remedies Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Enem Nostrum Remedies Private Limited amount to ₹ 40.62 Cr.
When was the last Balance Sheet of Enem Nostrum Remedies Private Limited filed with the ROC?
The most recent Balance Sheet for Enem Nostrum Remedies Private Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Prashant ReleDirectorJR
Jayant RanadeDirectorNR
Nalinkant RathodDirectorVM
Vasudeo MahajanDirector